DelMar Pharmaceuticals Inc (OTCQB:DMPI)

0.8001
Data as of Oct 24
 -0.0099 / -1.22%
Today’s Change
0.62
Today|||52-Week Range
1.60
-14.88%
Year-to-Date
SECTOR
Distribution Services
INDUSTRY
Wholesale Distributors
MARKET CAP
$24.1M

Company Description

DelMar Pharmaceuticals, Inc. is a development stage company with a focus on the development of drugs for the treatment of cancer. Its products include VAL-083, Drug Discovery and Patents & Intellectual Property. DelMar Pharmaceuticals was founded by Jeffrey Bacha, Dennis M. Brown and William J. Garner on June 24, 2009 and is headquartered in Vancouver, Canada.

Contact Information

DelMar Pharmaceuticals, Inc.
999 West Broadway
Vancouver British Columbia V5Z 1K5
P:(604) 629-5989
Investor Relations:

Employees

Shareholders

Individual stakeholders21.43%
Mutual fund holders--
Other institutional--

Top Executives

Jeffrey A. BachaChairman, President & Chief Executive Officer
Scott PraillChief Financial Officer
Dennis M. BrownDirector & Chief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.